Good morning!☕🗞️
Stay on top of your game with today's options setup and F&O headline makers.
Options setup (Expiry: 23 February)
| Nifty50 Max Call OI | 18,000 |
| Nifty50 Max Put OI | 17,500 |
| Max Pain | 17,900 |
| PCR | 0.85 |
| Bank Nifty Max Call OI | 41,500 |
| Bank Nifty Max Put OI | 40,000 |
| Max Pain | 40,900 |
| PCR | 0.61 |
⭐Sun Pharma plea rejected, shares tumble
₹973 ▼11 (-1.1%)
Sun Pharmaceutical shares fell more than 1%. The OI of its February futures contract rose 200%, indicating a short build-up. This comes after reports suggested that the company’s plea against the National Pharmaceutical Pricing Authority for price fixation of Acetazolamide IP 500 mg capsule was rejected. The medicine is used to prevent and reduce the symptoms of altitude sickness, headache, tiredness, nausea and dizziness.
⭐NTPC surges on govt order
₹173 ▲5 (+3.2%)
Shares of NTPC rose over 3% on Tuesday, while the OI of its February futures contract fell 39%, indicating a short covering. Meanwhile, the call option OI on the 175 and 175.75 contracts rose 231% and 12%, respectively. This comes after reports suggested that the government has asked imported coal-based power plants to run at full capacity for three months starting from 16 March. As the country braces for high temperatures, the ministry said power demand is expected to rise in April.
⭐HPCL hit by payment troubles
₹225 ▼ 5 (-2.4%)
Hindustan Petroleum Corporation settled 1% lower on Tuesday, while the OI of its February futures contract fell 50%, indicating a long unwinding. This comes after reports suggested that the oil refiner is facing issues with payments for Russian crude oil imports. The company is facing difficulties following a price cap imposed by western nations, as banks remain reluctant to process payments.
Disclaimer:
Derivatives trading must be done only by traders who fully understand the risks associated with them and strictly apply risk mechanisms like stop-losses. The information is only for consumption by the client and such material should not be redistributed. We do not recommend any particular stock, securities and strategies for trading. The securities quoted are exemplary and are not recommendatory. The stock names mentioned in this article are purely for showing how to do analysis. Take your own decision before investing.
Download the Upstox App Today